[Kinetic effect characterization of 0-beta-hydroxyethylrutoside (Venoruton) in healthy probands].
Identifieur interne : 002943 ( Ncbi/Merge ); précédent : 002942; suivant : 002944[Kinetic effect characterization of 0-beta-hydroxyethylrutoside (Venoruton) in healthy probands].
Auteurs : B. Ott [Allemagne] ; D. Rehn ; W. Nocker ; W. DiebschlagSource :
- VASA. Supplementum [ 0251-1029 ] ; 1991.
Descripteurs français
- KwdFr :
- MESH :
- analogues et dérivés : O-(bêta-Hydroxyéthyl)rutosides.
- pharmacologie : Anticoagulants, O-(bêta-Hydroxyéthyl)rutosides.
- physiologie : Perméabilité capillaire.
- physiopathologie : Lymphoedème.
- Humains, Perméabilité capillaire.
English descriptors
- KwdEn :
- MESH :
- chemical , analogs & derivatives : Hydroxyethylrutoside.
- chemical , pharmacology : Anticoagulants, Hydroxyethylrutoside.
- drug effects : Capillary Permeability.
- physiology : Capillary Permeability.
- physiopathology : Lymphedema.
- Humans.
PubMed: 1788678
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 005C37
- to stream PubMed, to step Curation: 005C37
- to stream PubMed, to step Checkpoint: 005C37
Links to Exploration step
pubmed:1788678Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Kinetic effect characterization of 0-beta-hydroxyethylrutoside (Venoruton) in healthy probands].</title>
<author><name sortKey="Ott, B" sort="Ott, B" uniqKey="Ott B" first="B" last="Ott">B. Ott</name>
<affiliation wicri:level="3"><nlm:affiliation>Zyma GmbH, Techn. Univ, München.</nlm:affiliation>
<country>Allemagne</country>
<placeName><settlement type="city">Munich</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
</placeName>
<wicri:orgArea>Zyma GmbH, Techn. Univ</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Rehn, D" sort="Rehn, D" uniqKey="Rehn D" first="D" last="Rehn">D. Rehn</name>
</author>
<author><name sortKey="Nocker, W" sort="Nocker, W" uniqKey="Nocker W" first="W" last="Nocker">W. Nocker</name>
</author>
<author><name sortKey="Diebschlag, W" sort="Diebschlag, W" uniqKey="Diebschlag W" first="W" last="Diebschlag">W. Diebschlag</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="1991">1991</date>
<idno type="RBID">pubmed:1788678</idno>
<idno type="pmid">1788678</idno>
<idno type="wicri:Area/PubMed/Corpus">005C37</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005C37</idno>
<idno type="wicri:Area/PubMed/Curation">005C37</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005C37</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005C37</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005C37</idno>
<idno type="wicri:Area/Ncbi/Merge">002943</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Kinetic effect characterization of 0-beta-hydroxyethylrutoside (Venoruton) in healthy probands].</title>
<author><name sortKey="Ott, B" sort="Ott, B" uniqKey="Ott B" first="B" last="Ott">B. Ott</name>
<affiliation wicri:level="3"><nlm:affiliation>Zyma GmbH, Techn. Univ, München.</nlm:affiliation>
<country>Allemagne</country>
<placeName><settlement type="city">Munich</settlement>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
</placeName>
<wicri:orgArea>Zyma GmbH, Techn. Univ</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Rehn, D" sort="Rehn, D" uniqKey="Rehn D" first="D" last="Rehn">D. Rehn</name>
</author>
<author><name sortKey="Nocker, W" sort="Nocker, W" uniqKey="Nocker W" first="W" last="Nocker">W. Nocker</name>
</author>
<author><name sortKey="Diebschlag, W" sort="Diebschlag, W" uniqKey="Diebschlag W" first="W" last="Diebschlag">W. Diebschlag</name>
</author>
</analytic>
<series><title level="j">VASA. Supplementum</title>
<idno type="ISSN">0251-1029</idno>
<imprint><date when="1991" type="published">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anticoagulants (pharmacology)</term>
<term>Capillary Permeability (drug effects)</term>
<term>Capillary Permeability (physiology)</term>
<term>Humans</term>
<term>Hydroxyethylrutoside (analogs & derivatives)</term>
<term>Hydroxyethylrutoside (pharmacology)</term>
<term>Lymphedema (physiopathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Anticoagulants (pharmacologie)</term>
<term>Humains</term>
<term>Lymphoedème (physiopathologie)</term>
<term>O-(bêta-Hydroxyéthyl)rutosides (analogues et dérivés)</term>
<term>O-(bêta-Hydroxyéthyl)rutosides (pharmacologie)</term>
<term>Perméabilité capillaire ()</term>
<term>Perméabilité capillaire (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Hydroxyethylrutoside</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anticoagulants</term>
<term>Hydroxyethylrutoside</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr"><term>O-(bêta-Hydroxyéthyl)rutosides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Capillary Permeability</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Anticoagulants</term>
<term>O-(bêta-Hydroxyéthyl)rutosides</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Perméabilité capillaire</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Capillary Permeability</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Perméabilité capillaire</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1788678</PMID>
<DateCreated><Year>1992</Year>
<Month>03</Month>
<Day>24</Day>
</DateCreated>
<DateCompleted><Year>1992</Year>
<Month>03</Month>
<Day>24</Day>
</DateCompleted>
<DateRevised><Year>2012</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0251-1029</ISSN>
<JournalIssue CitedMedium="Print"><Volume>33</Volume>
<PubDate><Year>1991</Year>
</PubDate>
</JournalIssue>
<Title>VASA. Supplementum</Title>
<ISOAbbreviation>Vasa Suppl</ISOAbbreviation>
</Journal>
<ArticleTitle>[Kinetic effect characterization of 0-beta-hydroxyethylrutoside (Venoruton) in healthy probands].</ArticleTitle>
<Pagination><MedlinePgn>218</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ott</LastName>
<ForeName>B</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Zyma GmbH, Techn. Univ, München.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Rehn</LastName>
<ForeName>D</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y"><LastName>Nocker</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y"><LastName>Diebschlag</LastName>
<ForeName>W</ForeName>
<Initials>W</Initials>
</Author>
</AuthorList>
<Language>ger</Language>
<PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
<VernacularTitle>Effektkinetische Charakterisierung von O-beta-Hydroxyethylrutosid (Venoruton) bei gesunden Freiwilligen.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Vasa Suppl</MedlineTA>
<NlmUniqueID>8704474</NlmUniqueID>
<ISSNLinking>0251-1029</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006896">Hydroxyethylrutoside</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>7Y4N11PXO8</RegistryNumber>
<NameOfSubstance UI="C005865">troxerutin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002199" MajorTopicYN="N">Capillary Permeability</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006896" MajorTopicYN="N">Hydroxyethylrutoside</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="Y">analogs & derivatives</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1991</Year>
<Month>1</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>1991</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>1991</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">1788678</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Bavière</li>
<li>District de Haute-Bavière</li>
</region>
<settlement><li>Munich</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Diebschlag, W" sort="Diebschlag, W" uniqKey="Diebschlag W" first="W" last="Diebschlag">W. Diebschlag</name>
<name sortKey="Nocker, W" sort="Nocker, W" uniqKey="Nocker W" first="W" last="Nocker">W. Nocker</name>
<name sortKey="Rehn, D" sort="Rehn, D" uniqKey="Rehn D" first="D" last="Rehn">D. Rehn</name>
</noCountry>
<country name="Allemagne"><region name="Bavière"><name sortKey="Ott, B" sort="Ott, B" uniqKey="Ott B" first="B" last="Ott">B. Ott</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002943 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002943 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:1788678 |texte= [Kinetic effect characterization of 0-beta-hydroxyethylrutoside (Venoruton) in healthy probands]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:1788678" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |